Wang, Chang https://orcid.org/0009-0005-1630-9453
Wang, Siyu
Xue, Yonger https://orcid.org/0000-0002-6022-2487
Zhong, Yichen
Li, Haoyuan
Hou, Xucheng
Kang, Diana D.
Liu, Zhengwei https://orcid.org/0009-0003-5105-6709
Tian, Meng
Wang, Leiming
Cao, Dinglingge
Yu, Yang https://orcid.org/0000-0001-6885-019X
Liu, Jayce
Cheng, Xiaolin
Markovic, Tamara
Hashemi, Alice
Kopell, Brian H.
Charney, Alexander W. https://orcid.org/0000-0001-8135-6858
Nestler, Eric J. https://orcid.org/0000-0002-7905-2000
Dong, Yizhou https://orcid.org/0000-0001-5786-0659
Funding for this research was provided by:
Icahn School of Medicine at Mount Sinai
Article History
Received: 25 April 2024
Accepted: 24 October 2024
First Online: 25 November 2024
Change Date: 4 March 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41587-025-02601-3
Competing interests
: Y.D. is a scientific advisor for Arbor Biotechnologies, siRNAgen Therapeutics and Moonwalk Biosciences. Y.D. is a cofounder and holds equity in Immunanoengineering Therapeutics. The other authors declare no competing interests.